Case Reports

Refeeding syndrome in a vegan patient with stage IV gastric cancer: a novel case


 

The refeeding syndrome encompasses the complex physiologic state that occurs in malnourished patients who receive nutrition after a period of decreased oral intake. The hallmark of the syndrome is hypophosphatemia, though other electrolyte imbalances and severe fluid shifts are commonly involved.1 Patients with newly diagnosed malignancies and those undergoing treatment for malignancies are at increased risk for developing the refeeding syndrome,2 however there are few reported cases or other data in the oncology literature regarding this syndrome in cancer patients.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Mutations found in almost 4% of pancreatic cancer patients
MDedge Hematology and Oncology
Smoking linked to many ‘new’ causes of death
MDedge Hematology and Oncology
HPV-16 E6 seropositivity common before anal cancer develops
MDedge Hematology and Oncology
Low marks for bevacizumab in cost/benefit analysis
MDedge Hematology and Oncology
Joint breast and colorectal cancer screenings in medically underserved women
MDedge Hematology and Oncology
Metastatic CRC treatment ‘dynamic and fast changing’
MDedge Hematology and Oncology
Death rates rising for liver cancer, falling for colorectal cancer
MDedge Hematology and Oncology
Tumor location portends CRC survival
MDedge Hematology and Oncology
Vegetarians less likely to develop colorectal cancer
MDedge Hematology and Oncology
Esophagogastric cancer patients on chemotherapy more likely to develop VTE
MDedge Hematology and Oncology